[18F]fluoroetanidazole ([18F]FETA) - A new promising PET marker for imaging stroke-related brain hypoxia

被引：0
|
作者：
Grossmann, U. [1 ]
Patt, M. [2 ]
Sorger, D. [2 ]
Wagner, D. [3 ]
Franke, H. [4 ]
Schildan, A. [2 ]
Boltze, J. [3 ]
Emmrich, F. [3 ]
Sabri, O. [2 ]
Barthel, H. [2 ]
机构：
[1] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany
[2] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany
[3] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany
[4] Univ Leipzig, Rudolph Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 50 条
  • [1] Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for hypoxia PET imaging
    Wack, L. J.
    Moennich, D.
    Van Elmpt, W.
    Zegers, C. M. L.
    Troost, E. G. C.
    Zips, D.
    Thorwarth, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S65 - S66
  • [2] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    Barthel, H
    Wilson, H
    Collingridge, DR
    Brown, G
    Osman, S
    Luthra, SK
    Brady, F
    Workman, P
    Price, PM
    Aboagye, EO
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2232 - 2242
  • [3] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    H Barthel
    H Wilson
    D R Collingridge
    G Brown
    S Osman
    S K Luthra
    F Brady
    P Workman
    P M Price
    E O Aboagye
    British Journal of Cancer, 2004, 90 : 2232 - 2242
  • [4] Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia
    Rasey, JS
    Hofstrand, PD
    Chin, LK
    Tewson, TJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (06) : 1072 - 1079
  • [5] In vivo evaluation of [18F]fluoroetanidazole for imaging tumour hypoxia with positron emission tomography (PET)
    Barthel, H
    Brown, G
    Wilson, H
    Collingridge, DR
    Price, PM
    Aboagye, EO
    BRITISH JOURNAL OF CANCER, 2002, 86 : S13 - S13
  • [6] Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia - a simulation study
    Wack, Linda J.
    Moennich, David
    Van Elmpt, Wouter
    Zegers, Catharina M. L.
    Troost, Esther G. C.
    Zips, Daniel
    Thorwarth, Daniela
    ACTA ONCOLOGICA, 2015, 54 (09) : 1370 - 1377
  • [7] PRECLINICAL EVALUATION OF [18F]HX4, A NOVEL AND PROMISING HYPOXIA MARKER FOR PET IMAGING
    Dubois, L.
    Lieuwes, N.
    Janssen, M.
    Secrest, J.
    Windhorst, A.
    Van Dongen, G.
    Kolb, H.
    Ollers, M.
    Zhang, J.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S7 - S7
  • [8] Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging
    Dubois, Ludwig J.
    Lieuwes, Natasja G.
    Janssen, Marco H. M.
    Peeters, Wenny J. M.
    Windhorst, Albert D.
    Walsh, Joseph C.
    Kolb, Hartmuth C.
    Ollers, Michel C.
    Bussink, Johan
    van Dongen, Guus A. M. S.
    van der Kogel, Albert
    Lambin, Philippe
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (35) : 14620 - 14625
  • [9] Pharmacokinetics of [18F]FETNIM:: A potential hypoxia marker for PET
    Grönroos, T
    Eskola, I
    Lehtiö, K
    Minn, H
    Marjamäki, P
    Bergman, J
    Haaparanta, M
    Forsback, S
    Solin, O
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (09) : 1397 - 1404
  • [10] [18F]FACBC and [18F]FLT PET Imaging for Glioblastomas (GBM)
    Grommes, Christian
    Akhurst, Timothy J.
    Blasberg, Ronald G.
    Beattie, Bradley J.
    Doubrovin, Mikhail
    Monaster, Jenna B.
    Lassman, Andrew B.
    NEUROLOGY, 2010, 74 (09) : A594 - A594
12345